Xing Jin

654 total citations · 1 hit paper
39 papers, 462 citations indexed

About

Xing Jin is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xing Jin has authored 39 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xing Jin's work include Ferroptosis and cancer prognosis (9 papers), Cancer-related molecular mechanisms research (9 papers) and RNA modifications and cancer (6 papers). Xing Jin is often cited by papers focused on Ferroptosis and cancer prognosis (9 papers), Cancer-related molecular mechanisms research (9 papers) and RNA modifications and cancer (6 papers). Xing Jin collaborates with scholars based in China, United States and Australia. Xing Jin's co-authors include Mark D. Simms, Zilong Wei, Liang Zhao, Cheng Zhan, Qun Wang, Jiaqi Liang, Guoshu Bi, Zhihan Wang, Min Li and Yunyi Bian and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Xing Jin

34 papers receiving 461 citations

Hit Papers

Examining the function of macrophage oxidative stress res... 2024 2026 2025 2024 10 20 30 40

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xing Jin China 14 259 107 98 77 60 39 462
Yi Zhong China 15 212 0.8× 137 1.3× 56 0.6× 98 1.3× 30 0.5× 39 441
Thorsten Biegner Germany 14 145 0.6× 140 1.3× 38 0.4× 115 1.5× 47 0.8× 18 577
Silvia Casagrande Italy 15 262 1.0× 51 0.5× 74 0.8× 160 2.1× 58 1.0× 27 592
Wenzhong Zhu China 11 153 0.6× 109 1.0× 30 0.3× 38 0.5× 24 0.4× 22 317
Shaima Salman United States 12 222 0.9× 159 1.5× 60 0.6× 96 1.2× 59 1.0× 24 542
Huali Lin China 12 194 0.7× 64 0.6× 23 0.2× 40 0.5× 43 0.7× 18 469
Xinxin Wang China 13 142 0.5× 49 0.5× 24 0.2× 58 0.8× 65 1.1× 29 551
Liwei Liao China 11 244 0.9× 112 1.0× 76 0.8× 120 1.6× 71 1.2× 31 454
Anne Suttkus Germany 12 200 0.8× 44 0.4× 47 0.5× 26 0.3× 18 0.3× 17 525
Zhaolong Yu United States 7 236 0.9× 46 0.4× 33 0.3× 40 0.5× 55 0.9× 12 505

Countries citing papers authored by Xing Jin

Since Specialization
Citations

This map shows the geographic impact of Xing Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Jin more than expected).

Fields of papers citing papers by Xing Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Jin. The network helps show where Xing Jin may publish in the future.

Co-authorship network of co-authors of Xing Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Xing Jin. A scholar is included among the top collaborators of Xing Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Jin. Xing Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Zhao, Liang, et al.. (2024). IGFBP7+ subpopulation and IGFBP7 risk score in astrocytoma: insights from scRNA-Seq and bulk RNA-Seq. Frontiers in Immunology. 15. 1434300–1434300. 1 indexed citations
5.
Sui, Qihai, et al.. (2024). The Research Progress of Metformin Regulation of Metabolic Reprogramming in Malignant Tumors. Pharmaceutical Research. 41(11). 2143–2159. 3 indexed citations
6.
Jin, Xing, Zhiheng Lin, Liang Zhao, et al.. (2024). Examining the function of macrophage oxidative stress response and immune system in glioblastoma multiforme through analysis of single-cell transcriptomics. Frontiers in Immunology. 14. 1288137–1288137. 49 indexed citations breakdown →
7.
Hu, Zhengyang, Xing Jin, Weifeng Hong, et al.. (2023). Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma. Cellular Oncology. 46(5). 1351–1368. 13 indexed citations
8.
Sui, Qihai, Zhengyang Hu, Jiaqi Liang, et al.. (2023). Targeting TAM-secreted S100A9 effectively enhances the tumor-suppressive effect of metformin in treating lung adenocarcinoma. Cancer Letters. 581. 216497–216497. 14 indexed citations
9.
Cheng, Ye, et al.. (2023). A novel prognostic signature and immune microenvironment characteristics associated with disulfidptosis in papillary thyroid carcinoma based on single-cell RNA sequencing. Frontiers in Cell and Developmental Biology. 11. 1308352–1308352. 7 indexed citations
10.
Zhang, Huan, Jiaqi Liang, Tao Lu, et al.. (2023). AGRN promotes lung adenocarcinoma progression by activating Notch signaling pathway and acts as a therapeutic target. Pharmacological Research. 194. 106819–106819. 18 indexed citations
11.
Jin, Xing, Zhengyang Hu, Qihai Sui, et al.. (2022). A Novel Prognostic Signature Revealed the Interaction of Immune Cells in Tumor Microenvironment Based on Single-Cell RNA Sequencing for Lung Adenocarcinoma. Journal of Immunology Research. 2022. 1–26. 7 indexed citations
12.
Yang, Huiqin, Xing Jin, Tao Cheng, et al.. (2022). Comprehensive Genome-Scale Analysis of Esophageal Carcinoma With Esophageal Tissue-Resident Micro-Environment Discrepancy. Frontiers in Microbiology. 13. 859352–859352. 1 indexed citations
13.
Jin, Xing, et al.. (2022). Single-Cell RNA Sequencing Reveals Cellular and Transcriptional Changes Associated With Traumatic Brain Injury. Frontiers in Genetics. 13. 861428–861428. 20 indexed citations
14.
Jin, Xing, Zhihan Wang, Hao Xu, et al.. (2020). Pak2 inhibition promotes resveratrol‐mediated glioblastoma A172 cell apoptosis via modulating the AMPK‐YAP signaling pathway. Journal of Cellular Physiology. 235(10). 6563–6573. 17 indexed citations
15.
Jin, Xing, et al.. (2019). Melatonin ameliorates endoplasmic reticulum stress in N2a neuroblastoma cell hypoxia-reoxygenation injury by activating the AMPK-Pak2 pathway. Cell Stress and Chaperones. 24(3). 621–633. 23 indexed citations
16.
Chen, Yuting, Yinghui Ji, Xing Jin, et al.. (2018). Mitochondrial abnormalities are involved in periodontal ligament fibroblast apoptosis induced by oxidative stress. Biochemical and Biophysical Research Communications. 509(2). 483–490. 37 indexed citations
17.
Zhang, Yunfeng, Qiang Guan, & Xing Jin. (2017). miR-200c serves an important role in H5V endothelial cells in high glucose by targeting Notch1. Molecular Medicine Reports. 16(2). 2149–2155. 10 indexed citations
18.
Huang, Guohui, Xi Yang, Xing Jin, et al.. (2016). Porf-2 Inhibits Neural Stem Cell Proliferation Through Wnt/β-Catenin Pathway by Its GAP Domain. Frontiers in Cellular Neuroscience. 10. 85–85. 13 indexed citations
19.
Simms, Mark D. & Xing Jin. (2015). Autism, Language Disorder, and Social (Pragmatic) Communication Disorder: DSM-V and Differential Diagnoses. Pediatrics in Review. 36(8). 355–363. 23 indexed citations
20.
Li, Min, Hua Zhou, Xing Jin, et al.. (2013). Autologous Bone Marrow Mononuclear Cells Transplant in Patients With Critical Leg Ischemia: Preliminary Clinical Results. Experimental and Clinical Transplantation. 11(5). 435–439. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026